Astera Labs (NASDAQ:ALAB) Upgraded at Northland Securities

Northland Securities upgraded shares of Astera Labs (NASDAQ:ALAB – Free Report) from a market perform rating to an outperform rating in a report published on Wednesday, Marketbeat reports. Northland Securities currently has $315.00 target price on the stock.

ALAB has been the subject of several other research reports. Jefferies Financial Group boosted their price objective on shares of Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. Needham & Company LLC lifted their target price on shares of Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. Morgan Stanley upped their price target on Astera Labs from $240.00 to $335.00 and gave the stock an “overweight” rating in a report on Monday, August 3rd. UBS Group restated a “neutral” rating and issued a $425.00 target price on shares of Astera Labs in a research note on Wednesday, August 5th. Finally, Zacks Research downgraded shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 5th. Thirteen investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $320.85.

Read Our Latest Stock Analysis on ALAB

Astera Labs Stock Performance

Astera Labs stock opened at $190.71 on Wednesday. The stock has a market capitalization of $33.09 billion, a price-to-earnings ratio of 75.98 and a beta of 3.85. The stock’s 50 day moving average price is $300.46 and its two-hundred day moving average price is $255.80. Astera Labs has a 52-week low of $97.89 and a 52-week high of $499.48.

Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its earnings results on Tuesday, November 3rd. The company reported $1.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.19 by $0.13. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $584.90 million during the quarter, compared to analyst estimates of $550.78 million. During the same period in the previous year, the firm earned $0.49 earnings per share. The business’s revenue was up 153.6% on a year-over-year basis. On average, equities research analysts forecast that Astera Labs will post 2.71 EPS for the current year.

Insider Activity at Astera Labs

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 8,994 shares of the business’s stock in a transaction dated Wednesday, October 7th. The shares were sold at an average price of $376.06, for a total transaction of $3,382,283.64. Following the sale, the director directly owned 2,648 shares of the company’s stock, valued at $995,806.88. The trade was a 77.25% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 6,801 shares of the stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the sale, the general counsel owned 96,542 shares of the company’s stock, valued at approximately $32,872,551. This represents a 6.58% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 396,059 shares of company stock valued at $123,408,470 over the last ninety days. Corporate insiders own 10.40% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

A number of large investors have recently bought and sold shares of the company. Keating Financial Advisory Services Inc. acquired a new stake in shares of Astera Labs in the 2nd quarter valued at approximately $25,000. Archer Investment Corp purchased a new stake in shares of Astera Labs in the second quarter worth $30,000. Transamerica Financial Advisors LLC purchased a new position in Astera Labs in the second quarter worth about $35,000. Continuum Advisory LLC purchased a new stake in Astera Labs during the second quarter valued at approximately $37,000. Finally, GK Wealth Management LLC acquired a new stake in Astera Labs during the third quarter valued at $29,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

More Astera Labs News

Here are the key news stories impacting Astera Labs this week:

About Astera Labs

(Get Free Report)

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems.

The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

Founded in 2017 and headquartered in Santa Clara, California, Astera Labs serves the global cloud and computing markets.

Featured Articles

Analyst Recommendations for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.